2003
DOI: 10.5414/cpp41200
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetics of lithium in healthy volunteers after exposure to high altitude

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
14
0
3

Year Published

2005
2005
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(18 citation statements)
references
References 0 publications
1
14
0
3
Order By: Relevance
“…Relative covariate importance for SMR with 95% bootstrap confidence intervals using the LMG method. that these changes might be clinically significant (Arancibia et al, 2003;Brahm and Puls, 2011). Yet, more research using experimental designs is needed to investigate the interaction between lithium and altitude in more detail.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Relative covariate importance for SMR with 95% bootstrap confidence intervals using the LMG method. that these changes might be clinically significant (Arancibia et al, 2003;Brahm and Puls, 2011). Yet, more research using experimental designs is needed to investigate the interaction between lithium and altitude in more detail.…”
Section: Discussionmentioning
confidence: 99%
“…These findings have been criticised for not controlling for possible confounding factors such as sociodemographic variables and the availability of mental health care, alleged to be a more plausible explanation for higher suicide rates in high-altitude regions (Betz et al, 2011(Betz et al, , 2012. Nevertheless, altitude is also known to have an effect on the pharmacokinetics and has been shown to significantly influence lithium pharmacokinetics in healthy humans (Arancibia et al, 2003). These changes were considered clinically relevant and there is indeed a report of potential altitude-induced hypomania in a bipolar adolescent person secondary to altitude-related changes in lithium pharmacokinetics (Brahm and Puls, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…The prevention and treatment of high-altitude illness [9][10][11] and pharmacokinetic differences in the processing of drugs such as sulfamethoxazole, lithium, acetazolamide, meperidine, and prednisolone at high altitudes have been studied [12][13][14][15] . These studies found significant changes in the disposition of drugs in healthy subjects after both acute and chronic exposure to high altitude.…”
Section: Introductionmentioning
confidence: 99%
“…A study of lithium in healthy volunteers has demonstrated that altitude can change the pharmacokinetics of lithium (Arancibia et al, 2003). Volunteers were administered 300 mg of lithium carbonate at 600 m above the mean sea level (MSL) at acute exposure (15 hours) and after chronic exposure (10 months) at 4,360 m above MSL.…”
Section: Introductionmentioning
confidence: 99%